Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder

Inclusion Criteria: * Participants aged between 18 and 64 years; * Participants diagnosed with insomnia disorder according to the criteria defined by the DSM-V (1) and who report sleep maintenance disorder; * Participants who agree not to use alcoholic beverages during the entire treatment period (6 weeks). Exclusion Criteria: * Participants with known hypersensitivity to the active ingredients used during the trial or who have exhibited complex sleep behavior after using them; * Participants with a history of alcohol, substance, or illicit drug abuse disorder in the last 2 years; * Women who are pregnant or breastfeeding, as well as women who have a positive result on a pregnancy test (β-hCG) during the screening period of the trial; * Participants diagnosed with severe liver failure;